AgaMatrix Gets $1.3M Fees From Dexcom's Failed IP Suit

Law360 (August 7, 2018, 7:39 PM EDT) -- A California federal judge has ruled that diabetes glucose monitoring company Dexcom Inc. must pay rival AgaMatrix Inc. more than $1.3 million in fees after proceeding with patent infringement litigation that bordered on bad faith.

U.S. District Judge S. James Otero said Monday that Dexcom must pay about $958,000 in attorneys’ fees for the work done by Schwabe Williamson & Wyatt PC and Lewis Roca Rothgerber Christie LLP, along with another $311,000 in expert fees and $77,000 in expenses, for a total of $1,345,816.30.

“Needless to say, we are pleased,” Schwabe Williamson shareholder Nika F. Aldrich told Law360.

Counsel for Dexcom...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!